Delivery Order SPE2DB20D3103-SPE2DB23FP2M4

Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $754
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from August 11-14, 2023. The contract was awarded utilizing the Defense Logistics Agency's Pharmaceutical Prime Vendor program, which provides pharmaceuticals and other medical supplies to...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml doses of XYOSTED, an auto-injectable testosterone treatment, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and provisioning medical...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $452.70 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period beginning August 1, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $860 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a testosterone replacement drug. Performance will take place in Conshohocken, Pennsylvania over a one day period from August 30th to August 31st, 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, responsible for...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $533 delivery order by the Defense Logistics Agency to supply 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone therapy, for delivery to a location in Conshohocken, Pennsylvania from July 21-24, 2023. The firm fixed price contract was issued utilizing the DLA's Pharmaceutical Prime Vendor program, which centrally manages pharmaceuticals for the Department of Defense and other...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251,420 delivery order by the Defense Logistics Agency to supply XYOSTED 75 MG/0.5 ML auto-injectors. Performance will take place in Conshohocken, Pennsylvania under firm fixed pricing over a period of four days from August 4th through the 7th of 2023. The Defense Logistics Agency is the logistics combat support agency of the United States Department of Defense, charged with sourcing and...
Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical Center. This $1,575.18 order is for the supply of 75 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication, to be delivered by December 5, 2023 to the place of performance in Conshohocken, Pennsylvania. As a prime contractor supporting DLA Troop...
Amerisourcebergen Drug Corp has received a firm fixed price delivery order for $1,443.02 from the Defense Logistics Agency (DLA) to supply 100 mg/0.5 ml doses of XYOSTED, an auto-injectable testosterone medication. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with all supplies delivered by November 2, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with DLA Troop Support Medical to provide pharmaceuticals and...
Amerisourcebergen Drug Corp has been awarded a $1,002.12 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical contract vehicle to supply 50 MG/0.5 ML auto-injectors of XYOSTED, a medication for testosterone replacement therapy. Performance will occur in Conshohocken, Pennsylvania by October 2023. The Defense Logistics Agency supports military readiness by procuring and providing medical supplies and pharmaceuticals to the Department of Defense. No...
Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $251 firm fixed price delivery order by the Defense Logistics Agency to supply 100mg/0.5ml auto-injectors of XYOSTED, a medication used to treat conditions such as hypogonadism. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on August 29, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB23FP2M4
    Delivery Order

Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $754.26 firm fixed price delivery order by the Defense Logistics Agency to supply 50mg/0.5ml doses of XYOSTED, an auto-injectable testosterone therapy, for performance in Conshohocken, Pennsylvania from August 4-7, 2023. As the prime contractor for delivery order under an unspecified agency-wide contract vehicle, Amerisourcebergen will fulfill the Defense Logistics Agency's requirement for this prescription medication to support its provision of health services to military personnel. No subcontractors or set-aside designations were indicated in the award information.

Generated 12/20/23, 3:21 AM